文献速递产科母胎医学

青少年和年轻成人癌症幸存者的母亲合并症与不良围产期结局:一项队列研究

Maternal comorbidity and adverse perinatal outcomes in survivors of adolescent and young adult cancer: A cohort study.
PubMed 文献 · BJOG · 2023-02-02

该回顾性队列研究基于美国商业保险理赔数据,纳入2000–2019年活产女性,评估青少年和年轻成人癌症幸存者早产和严重孕产妇并发症风险及母亲合并症的中介作用,并分析辅助生殖技术是否影响关联。

要点

  • 癌症幸存者单胎早产发生率为14.8%,无癌女性为12.4%(aRR 1.19,95% CI 1.06-1.34)。
  • 癌症幸存者单胎严重孕产妇并发症发生率为3.9%,无癌女性为2.4%(aRR 1.44,95% CI 1.13-1.83)。
  • 癌症与早产关联的26%及与严重孕产妇并发症关联的30%由母亲合并症介导。

核心结论

  • 癌症后早产和严重孕产妇并发症风险轻度增加,其风险升高可能部分源于合并症增加,辅助生殖技术未显著改变该关联,预防和治疗合并症为改善癌症幸存者围产结局提供机会。

研究设计与样本

  • 回顾性队列研究,数据来自美国去标识化行政健康理赔数据集,纳入2000–2019年活产女性,采用对数二项回归模型估计相对风险并用因果中介分析评估合并症解释比例。

主要发现

  • 在46 064名癌症幸存者中,癌症诊断后有2 440例单胎活产、214例多胎活产和2 590名关联新生儿。
  • 单胎活产中,早产发生率癌症幸存者为14.8%,无癌女性为12.4%(aRR 1.19,95% CI 1.06-1.34)。
  • 单胎活产中,严重孕产妇并发症发生率癌症幸存者为3.9%,无癌女性为2.4%(aRR 1.44,95% CI 1.13-1.83)。
  • 癌症幸存者孕前和孕期合并症更多;癌症与早产关联的26%及与严重孕产妇并发症关联的30%由母亲合并症介导。
  • 辅助生殖技术对癌症状态与围产结局关联的效应修饰检验无显著意义。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate risks of preterm birth (PTB) and severe maternal morbidity (SMM) in female survivors of adolescent and young adult cancer and assess maternal comorbidity as a potential mechanism. To determine whether associations differ by use of assisted reproductive technology (ART). DESIGN: Retrospective cohort. SETTING: Commercially insured females in the USA. SAMPLE: Females with live births from 2000-2019 within a de-identified US administrative health claims data set. METHODS: Log-binomial regression models estimated relative risks of PTB and SMM by cancer status and tested for effect modification. Causal mediation analysis evaluated the proportions explained by maternal comorbidity. MAIN OUTCOME MEASURES: PTB and SMM. RESULTS: Among 46 064 cancer survivors, 2440 singleton births, 214 multiple births and 2590 linked newborns occurred after cancer diagnosis. In singleton births, the incidence of PTB was 14.8% in cancer survivors versus 12.4% in females without cancer (aRR 1.19, 95% CI 1.06-1.34); the incidence of SMM was 3.9% in cancer survivors versus 2.4% in females without cancer (aRR 1.44, 95% CI 1.13-1.83). Cancer survivors had more maternal comorbidities before and during pregnancy; 26% of the association between cancer and PTB and 30% of the association between cancer and SMM was mediated by maternal comorbidities. Tests for effect modification of cancer status on perinatal outcomes by ART were non-significant. CONCLUSIONS: Preterm birth and SMM risks were modestly increased after cancer. Significant proportions of elevated risks may result from increased comorbidities. ART did not significantly modify the association between adolescent and young adult cancer and adverse perinatal outcomes. The prevention and treatment of comorbidities provides an opportunity to improve perinatal outcomes among cancer survivors.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Desai M, Zhou B, Nalawade V, et al. Maternal comorbidity and adverse perinatal outcomes in survivors of adolescent and young adult cancer: A cohort study. BJOG. 2023. PMID: 36655360. doi:10.1111/1471-0528.17380

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。